Anti-Polyethylene glycol 抗体 [PEG-B-47] (ab51257)

ab51257 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab51257 は 31 報の論文で使用されています。

  • Rasmussen CE  et al. Evaluation of Nonacog Beta Pegol Long-term Safety in the Immune-deficient Rowett Nude Rat (Crl:NIH-Foxn1rnu ). Toxicol Pathol N/A:N/A (2016). ICC/IF . PubMed: 26940713
  • Lubich C  et al. The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know? Pharm Res N/A:N/A (2016). ELISA, IHC, Flow Cyt . PubMed: 27271335
  • der Valk FM  et al. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. Nanomedicine N/A:N/A (2015). PubMed: 25791806
  • Schneck E  et al. Neutron reflectometry from poly (ethylene-glycol) brushes binding anti-PEG antibodies: evidence of ternary adsorption. Biomaterials 46:95-104 (2015). PubMed: 25678119
  • Poirier N  et al. FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft. Am J Transplant 15:88-100 (2015). PubMed: 25488654
  • Jiang Y  et al. SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature. J Control Release 213:36-44 (2015). PubMed: 26093094
  • Schulz M  et al. Lateral surface engineering of hybrid lipid-BCP vesicles and selective nanoparticle embedding. Soft Matter 10:831-9 (2014). PubMed: 24837370
  • Eriksson PO  et al. Novel nano-sized MR contrast agent mediates strong tumor contrast enhancement in an oncogene-driven breast cancer model. PLoS One 9:e107762 (2014). IHC . PubMed: 25296030
  • Hashimoto Y  et al. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs. Toxicol Appl Pharmacol 277:30-8 (2014). PubMed: 24632081
  • Saifer MG  et al. Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins. Mol Immunol 57:236-46 (2014). ELISA . PubMed: 24200843
  • Myers DE  et al. CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells. Integr Biol (Camb) 6:766-80 (2014). WB . PubMed: 24910947
  • Yadav VR  et al. Biological Evaluation of Liposome-Encapsulated Hemoglobin Surface-Modified With a Novel PEGylated Nonphospholipid Amphiphile. Artif Organs N/A:N/A (2014). IHC . PubMed: 24749870
  • Shiraishi K  et al. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. J Control Release 165:183-90 (2013). ELISA . PubMed: 23220106
  • Zhang J  et al. Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection. Biomaterials 34:3846-57 (2013). Flow Cyt . PubMed: 23403120
  • Nag OK  et al. Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo. Int J Pharm 446:119-29 (2013). ELISA . PubMed: 23419666
  • Jen J  et al. Pegvisomant bioavailability of single 30 mg/mL subcutaneous injection compared to two 15 mg/mL subcutaneous injections: a pharmacokinetic, safety and tolerability study. Growth Horm IGF Res 23:114-9 (2013). ELISA . PubMed: 23651793
  • Rudmann DG  et al. High Molecular Weight Polyethylene Glycol Cellular Distribution and PEG-associated Cytoplasmic Vacuolation Is Molecular Weight Dependent and Does Not Require Conjugation to Proteins. Toxicol Pathol 41:970-83 (2013). IHC . PubMed: 23788571
  • Hendriks BS  et al. Impact of tumor HER2/ERBB2 expression level on HER2-targeted liposomal doxorubicin-mediated drug delivery: multiple low-affinity interactions lead to a threshold effect. Mol Cancer Ther 12:1816-28 (2013). PubMed: 23723124
  • Schwöppe C  et al. Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor. J Med Chem 56:2337-47 (2013). WB . PubMed: 23496322
  • Desale SS  et al. Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. J Control Release 171:339-48 (2013). IHC-P . PubMed: 23665258
  • Bitner BR  et al. Antioxidant carbon particles improve cerebrovascular dysfunction following traumatic brain injury. ACS Nano 6:8007-14 (2012). ICC/IF . PubMed: 22866916
  • Sherman MR  et al. Role of the methoxy group in immune responses to mPEG-protein conjugates. Bioconjug Chem 23:485-99 (2012). PubMed: 22332808
  • Cong Y  et al. Site-specific PEGylation at histidine tags. Bioconjug Chem 23:248-63 (2012). PubMed: 22243664
  • Elliott VL  et al. Evidence for metabolic cleavage of a PEGylated protein in vivo using multiple analytical methodologies. Mol Pharm 9:1291-301 (2012). WB . PubMed: 22480236
  • Cheng TL  et al. Analytical measurement of PEGylated molecules. Bioconjug Chem 23:881-99 (2012). ELISA . PubMed: 22242549
  • Oberoi HS  et al. Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice. Int J Nanomedicine 7:2557-71 (2012). IHC-P . PubMed: 22745537
  • Wang SJ  et al. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies. Anal Bioanal Chem 402:1229-39 (2012). ELISA . PubMed: 22130720
  • Burtea C  et al. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Arterioscler Thromb Vasc Biol 32:e36-48 (2012). PubMed: 22516067
  • Xu Y  et al. Immunoaffinity purification using anti-PEG antibody followed by two-dimensional liquid chromatography/tandem mass spectrometry for the quantification of a PEGylated therapeutic peptide in human plasma. Anal Chem 82:6877-86 (2010). AP . PubMed: 20704377
  • Su YC  et al. Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies. Bioconjug Chem 21:1264-70 (2010). PubMed: 20536171
  • Sakai H  et al. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days. Shock 31:192-200 (2009). PubMed: 18520699